| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/14/2002 | WO2001058474A3 Microencapsulation and sustained release of biologically active agent |
| 02/14/2002 | WO2001055092A3 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 02/14/2002 | WO2001054675A3 Pharmaceutical compositions comprising terbinafine |
| 02/14/2002 | WO2001053463A3 COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF HER-2/neu ASSOCIATED MALIGNANCIES |
| 02/14/2002 | WO2001049705A3 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 02/14/2002 | WO2001049685A3 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 02/14/2002 | WO2001049274A3 Methods for pulmonary delivery of interleukin-2 |
| 02/14/2002 | WO2001049252A3 Oil-in-water type cosmetic or dermatological preparations |
| 02/14/2002 | WO2000073337A9 Polymer conjugates of hedgehog proteins and uses |
| 02/14/2002 | WO1995022992A8 Method and compositions for increasing the serum half-life of pharmacologically active agents |
| 02/14/2002 | US20020019446 Polymeric drug formulations |
| 02/14/2002 | US20020019445 Topical applying |
| 02/14/2002 | US20020019442 Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications |
| 02/14/2002 | US20020019437 Aids therapy |
| 02/14/2002 | US20020019431 Porous celecoxib matrices and methods of manufacture thereof |
| 02/14/2002 | US20020019369 Injectable drug delivery systems with cyclodextrin-polymer based hydrogels |
| 02/14/2002 | US20020019365 Encapsulation is dissolution resistant at a pH of about 4 to 5 or less and dissolves at a pH of greater than about 4 to 5 |
| 02/14/2002 | US20020019360 Treatment for cardiovascular disease |
| 02/14/2002 | US20020019358 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics |
| 02/14/2002 | US20020019354 Method of treatment of seborrheic dermatitis |
| 02/14/2002 | US20020019353 Single-dose administration |
| 02/14/2002 | US20020019343 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol |
| 02/14/2002 | US20020019340 Polymer stabilized neuropeptides |
| 02/14/2002 | US20020019338 Ontaining alpha difluoromethylornithine (2-difluoromethyl-2,5-diaminopentanoic acid) DFMO with a polycation selected from polycationic carbohydrate, polyamine, polypeptide, a basic polymer and polyamino acid |
| 02/14/2002 | US20020019336 Sustained release drug compositions |
| 02/14/2002 | US20020019334 Nutritional intervention composition for enhancing and extending satiety |
| 02/14/2002 | US20020019041 Storing adenoviruses; preparing liquid composition, maintain liquid at freezing, monitor adenovirues for activity |
| 02/14/2002 | US20020019039 A chemically modified mutant protein, e.g. an enzyme, having a substituted cysteine reacted with a glyosyslated thiosulfate; high esterase activity and low amidase activity of subtilisins; protease to degrade lectins |
| 02/14/2002 | US20020018819 Heating, pulverization; cyclodextrin solubilizers |
| 02/14/2002 | US20020018814 Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use |
| 02/14/2002 | US20020018812 Sponge-like or foam |
| 02/14/2002 | US20020018810 Controlled release oxycodone compositions |
| 02/14/2002 | US20020018807 Mixture of cocoa plant extract and antichloesterol agent |
| 02/14/2002 | US20020018804 Biological bioadhesive composition and methods of preparation and use |
| 02/14/2002 | US20020018775 Complexing; separation; gene therapy |
| 02/14/2002 | US20020018753 Mixture of drug, propellant and solvent |
| 02/14/2002 | US20020018751 Cellular and serum protein anchors for diagnostic imaging |
| 02/14/2002 | US20020018750 Anticancer agents |
| 02/14/2002 | US20020018749 High avidity polyvalent and polyspecific reagents |
| 02/14/2002 | US20020018732 Buffer solution for contact lenses |
| 02/14/2002 | DE10038641A1 Vitamin A composition used for treating e.g. vitamin A deficiency and ophthalmological disorders includes phytol or phytol derivative to reduce teratogenic effects |
| 02/14/2002 | DE10038571A1 Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen Compositions and dosage forms for use in the oral cavity in Bhandlung mycoses |
| 02/14/2002 | DE10036871A1 Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe Dispersions for the formulation of poorly soluble drugs or little |
| 02/14/2002 | DE10035991A1 Nagellackzusammensetzung Nail polish composition |
| 02/14/2002 | DE10035891A1 Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen Medical adhesive with a two-phase adhesive matrix of polyacrylates and polyamine salts |
| 02/14/2002 | DE10031043A1 Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung Delayed-release preparations of quinolone antibiotics and methods for their preparation |
| 02/14/2002 | CA2634715A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy}-11.beta.-hydroxy-16.alpha-methyl-3-oxo-androsta-1,4-diene-17.beta.carbothioic acids-fluoromethyl ester as an anti-inflammatory agent |
| 02/14/2002 | CA2418960A1 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
| 02/14/2002 | CA2418915A1 Stable pergolide mesylate and process for making same |
| 02/14/2002 | CA2418907A1 Hydrogel-driven drug dosage form |
| 02/14/2002 | CA2418383A1 Radiolabelled metal transport proteins as imaging agents |
| 02/14/2002 | CA2417930A1 Pharmaceutical compositions containing lithium carbonate |
| 02/14/2002 | CA2417826A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | CA2417755A1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 02/14/2002 | CA2417225A1 Electro-powder |
| 02/14/2002 | CA2416767A1 Liquid formulation of metformin |
| 02/14/2002 | CA2416531A1 Compositions for preventing urinary calculus |
| 02/14/2002 | CA2386725A1 Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 02/13/2002 | EP1179541A1 Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 02/13/2002 | EP1179353A1 Antithrombogenic implants with coating of polyphosphazenes and a pharmacologically active agent |
| 02/13/2002 | EP1179349A1 W/O emulsion adjuvant compositions for vaccines |
| 02/13/2002 | EP1179344A1 Release-regulating preparations |
| 02/13/2002 | EP1179078A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses |
| 02/13/2002 | EP1178848A1 Bioadhesive hydrogels with functionalized degradable crosslinks |
| 02/13/2002 | EP1178838A2 Macromolecular carrier for drug and diagnostic agent delivery |
| 02/13/2002 | EP1178836A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues |
| 02/13/2002 | EP1178834A1 Controlled release of growth factors from heparin containing matrices |
| 02/13/2002 | EP1178833A1 Topical compositions for prostaglandin e 1? delivery |
| 02/13/2002 | EP1178828A1 Death domain containing receptor 4 |
| 02/13/2002 | EP1178818A1 A stable composition comprising epidermal growth factor as an active ingredient |
| 02/13/2002 | EP1178811A1 Electrolyte gels for maintaining hydration and rehydration |
| 02/13/2002 | EP1178809A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
| 02/13/2002 | EP1178808A1 Pharmaceutical composition |
| 02/13/2002 | EP1178799A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 02/13/2002 | EP1178798A1 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate) |
| 02/13/2002 | EP1178786A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/13/2002 | EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response |
| 02/13/2002 | EP1178783A1 Device and method for increasing the transdermal permeation of medicaments |
| 02/13/2002 | EP1178782A2 Transdermal therapeutic system (tts) containing tolterodine |
| 02/13/2002 | EP1178781A1 Multilayer pharmaceutical product for release in the colon |
| 02/13/2002 | EP1178780A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 02/13/2002 | EP1178778A2 Granules containing a plant substance and method for producing the same |
| 02/13/2002 | EP1178740A1 New composition |
| 02/13/2002 | EP1178736A1 A composition containing carvacrol and thymol for use as a bactericide |
| 02/13/2002 | EP0865289B1 Arctium majus compositions |
| 02/13/2002 | EP0847273B1 Improved pharmaceutical ion exchange resin composition |
| 02/13/2002 | EP0830142B1 Prrs (porcine reproductive and respiratory syndrome) virus vaccine |
| 02/13/2002 | EP0814781B1 Long-shelf-life medicaments |
| 02/13/2002 | CN1335887A Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 02/13/2002 | CN1335885A Powdery compositions of liquid aureobasidium culture, process for producing the same and powdery mixtures by using these composition |
| 02/13/2002 | CN1335787A Apparatus and process for preparing crystalline particles |
| 02/13/2002 | CN1335769A Controlled release formulation of divalproex sodium |
| 02/13/2002 | CN1335768A Multiparticulate modified release composition |
| 02/13/2002 | CN1335767A Sustained release matrix systems for highly soluble drugs |
| 02/13/2002 | CN1335765A Polyol/oil suspensions for the sustained release of proteins |
| 02/13/2002 | CN1335764A Substrate composition and method of use for sequestration of skin irritants |
| 02/13/2002 | CN1335749A Method and compositions for treatment of cell proliferative disorders |
| 02/13/2002 | CN1335381A Low temperature production process of matrix oil for sea-buckthorn medicine |
| 02/13/2002 | CN1335181A Antifungal medicine synergist and its prepn and application |
| 02/12/2002 | US6346634 Chemical compound containing a superoxide scavenger and an organic nitrate or nitrite moiety |